Equity Capital Markets

Company · CIK 1656328

Sienna Biopharmaceuticals, Inc.

CIK1656328 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2017-09-07

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-226595
ShelfEffective
 2018-08-032019-12-166
333-219142
IPOFinal prospectus
 2017-07-032017-07-275

Filings

12
FiledFilingRegistrationAccession
2019-12-16EFFECTDeclared effective 333-2265959999999995-19-002814
2019-02-21424B5Shelf takedown 333-2265950001193125-19-047116
2019-02-19424B5Shelf takedown 333-2265950001193125-19-044364
2018-08-23424B5Shelf takedown 333-2265950001193125-18-256325
2018-08-14EFFECTDeclared effective 333-2265959999999995-18-002100
2018-08-03S-3Shelf registered 333-2265950001193125-18-238566
2017-07-27424B4Final prospectus 333-2191420001193125-17-238703
2017-07-26EFFECTDeclared effective 333-2191429999999995-17-001925
2017-07-24S-1/AAmendment 333-2191420000950123-17-006251
2017-07-17S-1/AAmendment 333-2191420001193125-17-228984
2017-07-03S-1Registration filed 333-2191420001193125-17-221074
2017-05-15DRSDraft made public 377-015750000950123-17-005317

All filings of this company · CSV